|
LTV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.73919999974559E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.75510000000245E-05 |
| Normal-vs-Stage2 |
8.603900E-04 |
| Normal-vs-Stage3 |
6.33169999986194E-07 |
| Normal-vs-Stage4 |
1.11099999977604E-07 |
| Stage1-vs-Stage2 |
6.857200E-01 |
| Stage1-vs-Stage3 |
6.361900E-02 |
| Stage1-vs-Stage4 |
4.844100E-02 |
| Stage2-vs-Stage3 |
4.108800E-01 |
| Stage2-vs-Stage4 |
2.476400E-01 |
| Stage3-vs-Stage4 |
6.162600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.22839999961278E-07 |
| Normal-vs-AfricanAmerican |
2.200900E-04 |
| Normal-vs-Asian |
4.301600E-03 |
| Caucasian-vs-AfricanAmerican |
5.493400E-01 |
| Caucasian-vs-Asian |
3.442000E-01 |
| AfricanAmerican-vs-Asian |
2.889400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.20610000454403E-08 |
| Normal-vs-Female |
1.6660499999932E-05 |
| Male-vs-Female |
1.110000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.63500000000183E-05 |
| Normal-vs-Age(41-60Yrs) |
1.05240000003448E-06 |
| Normal-vs-Age(61-80Yrs) |
4.44990000003642E-06 |
| Normal-vs-Age(81-100Yrs) |
2.830200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.649440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.402000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.374200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.095400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.792800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.634000E-01 |
| Classical-VS-Follicular |
4.500600E-01 |
| Classical-VS-Other |
9.154300E-02 |
| Classical-VS-Normal |
1.55706999999117E-05 |
| Tall-VS-Follicular |
9.235200E-01 |
| Tall-VS-Other |
2.539200E-01 |
| Tall-VS-Normal |
5.637400E-04 |
| Follicular-VS-Other |
2.994000E-01 |
| Follicular-VS-Normal |
9.82720000000104E-05 |
| Other-VS-Normal |
1.382750E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.30990000022113E-07 |
| Normal-vs-N1 |
1.93665000000065E-05 |
| N0-vs-N1 |
6.259200E-01 |
|
|
